• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

USP 去泛素化酶催化机制的多样性。

Variety in the USP deubiquitinase catalytic mechanism.

机构信息

https://ror.org/03xqtf034 Division of Biochemistry and Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands.

Max Planck Institute of Molecular Physiology, Chemical Genomics Centre, Dortmund, Germany.

出版信息

Life Sci Alliance. 2024 Feb 14;7(4). doi: 10.26508/lsa.202302533. Print 2024 Apr.

DOI:10.26508/lsa.202302533
PMID:38355287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10867860/
Abstract

The ubiquitin-specific protease (USP) family of deubiquitinases (DUBs) controls cellular ubiquitin-dependent signaling events. This generates therapeutic potential, with active-site inhibitors in preclinical and clinical studies. Understanding of the USP active site is primarily guided by USP7 data, where the catalytic triad consists of cysteine, histidine, and a third residue (third critical residue), which polarizes the histidine through a hydrogen bond. A conserved aspartate (fourth critical residue) is directly adjacent to this third critical residue. Although both critical residues accommodate catalysis in USP2, these residues have not been comprehensively investigated in other USPs. Here, we quantitatively investigate their roles in five USPs. Although USP7 relies on the third critical residue for catalysis, this residue is dispensable in USP1, USP15, USP40, and USP48, where the fourth critical residue is vital instead. Furthermore, these residues vary in importance for nucleophilic attack. The diverging catalytic mechanisms of USP1 and USP7 are independent of substrate and retained in cells for USP1. This unexpected variety of catalytic mechanisms in this well-conserved protein family may generate opportunities for selective targeting of individual USPs.

摘要

泛素特异性蛋白酶 (USP) 家族的去泛素化酶 (DUBs) 控制细胞内依赖泛素的信号事件。这为治疗提供了潜力,在临床前和临床研究中使用活性位点抑制剂。USP7 数据主要指导了对 USP 活性位点的理解,其中催化三联体由半胱氨酸、组氨酸和第三个关键残基(第三个关键残基)组成,通过氢键使组氨酸极性化。一个保守的天冬氨酸(第四个关键残基)直接位于第三个关键残基旁边。尽管 USP2 中的这两个关键残基都适应了催化作用,但其他 USPs 中尚未全面研究这些残基。在这里,我们定量研究了它们在五个 USPs 中的作用。虽然 USP7 依赖于第三个关键残基进行催化,但在 USP1、USP15、USP40 和 USP48 中,该残基是可有可无的,而第四个关键残基则至关重要。此外,这些残基在亲核攻击中的重要性也不同。USP1 和 USP7 的不同催化机制与底物无关,并且在细胞中保留了 USP1 的催化机制。在这个高度保守的蛋白质家族中,这种出乎意料的催化机制多样性可能为选择性靶向个别 USP 提供机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/97b087d85088/LSA-2023-02533_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/1784ade9eaaa/LSA-2023-02533_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/67a7bfa69ad0/LSA-2023-02533_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/3a4a75cc53dc/LSA-2023-02533_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/8dab7362ed7e/LSA-2023-02533_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/40e6da9ace84/LSA-2023-02533_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/ebe930d78d92/LSA-2023-02533_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/152311c11ffd/LSA-2023-02533_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/cc8bf385e36b/LSA-2023-02533_FigS5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/4f335e1c4c81/LSA-2023-02533_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/6df2b0fbfbe2/LSA-2023-02533_FigS6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/97b087d85088/LSA-2023-02533_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/1784ade9eaaa/LSA-2023-02533_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/67a7bfa69ad0/LSA-2023-02533_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/3a4a75cc53dc/LSA-2023-02533_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/8dab7362ed7e/LSA-2023-02533_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/40e6da9ace84/LSA-2023-02533_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/ebe930d78d92/LSA-2023-02533_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/152311c11ffd/LSA-2023-02533_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/cc8bf385e36b/LSA-2023-02533_FigS5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/4f335e1c4c81/LSA-2023-02533_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/6df2b0fbfbe2/LSA-2023-02533_FigS6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/10867860/97b087d85088/LSA-2023-02533_Fig5.jpg

相似文献

1
Variety in the USP deubiquitinase catalytic mechanism.USP 去泛素化酶催化机制的多样性。
Life Sci Alliance. 2024 Feb 14;7(4). doi: 10.26508/lsa.202302533. Print 2024 Apr.
2
Contribution of active site residues to substrate hydrolysis by USP2: insights into catalysis by ubiquitin specific proteases.USP2 催化残基对底物水解的贡献:泛素特异性蛋白酶催化作用的深入了解。
Biochemistry. 2011 May 31;50(21):4775-85. doi: 10.1021/bi101958h. Epub 2011 May 4.
3
The structure of the deubiquitinase USP15 reveals a misaligned catalytic triad and an open ubiquitin-binding channel.去泛素化酶 USP15 的结构揭示了一个错位的催化三联体和一个开放的泛素结合通道。
J Biol Chem. 2018 Nov 9;293(45):17362-17374. doi: 10.1074/jbc.RA118.003857. Epub 2018 Sep 18.
4
The WD40-repeat protein-containing deubiquitinase complex: catalysis, regulation, and potential for therapeutic intervention.WD40 重复蛋白包含的去泛素化酶复合物:催化、调控及潜在的治疗干预作用。
Cell Biochem Biophys. 2013 Sep;67(1):111-26. doi: 10.1007/s12013-013-9637-1.
5
Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders.泛素特异性蛋白酶(USPs)与代谢紊乱。
Int J Mol Sci. 2023 Feb 6;24(4):3219. doi: 10.3390/ijms24043219.
6
Validation of catalytic site residues of Ubiquitin Specific Protease 2 (USP2) by molecular dynamic simulation and novel kinetics assay for rational drug design.通过分子动力学模拟和新型动力学测定法对泛素特异性蛋白酶 2 (USP2)的催化位点残基进行验证,为合理药物设计提供依据。
Mol Divers. 2023 Jun;27(3):1323-1332. doi: 10.1007/s11030-022-10499-1. Epub 2022 Aug 6.
7
Mutations in the 'Fingers' subdomain of the deubiquitinase USP1 modulate its function and activity.去泛素化酶USP1的“手指”亚结构域中的突变会调节其功能和活性。
FEBS J. 2016 Mar;283(5):929-46. doi: 10.1111/febs.13648. Epub 2016 Feb 3.
8
Ubiquitin-specific peptidase 1: assessing its role in cancer therapy.泛素特异性蛋白酶1:评估其在癌症治疗中的作用。
Clin Exp Med. 2023 Nov;23(7):2953-2966. doi: 10.1007/s10238-023-01075-4. Epub 2023 Apr 24.
9
Discovery and characterization of potent macrocycle inhibitors of ubiquitin-specific protease-7.泛素特异性蛋白酶-7强效大环抑制剂的发现与表征
Structure. 2025 Apr 3;33(4):705-717.e4. doi: 10.1016/j.str.2025.01.021. Epub 2025 Feb 20.
10
Ubiquitin-specific Protease 15 Negatively Regulates Virus-induced Type I Interferon Signaling via Catalytically-dependent and -independent Mechanisms.泛素特异性蛋白酶15通过催化依赖性和非依赖性机制负向调节病毒诱导的I型干扰素信号传导。
Sci Rep. 2015 Jun 10;5:11220. doi: 10.1038/srep11220.

引用本文的文献

1
USP1/UAF1 targets polyubiquitinated PCNA with an exo-cleavage mechanism that can temporarily enrich for monoubiquitinated PCNA.USP1/UAF1通过一种外切切割机制靶向多聚泛素化的增殖细胞核抗原(PCNA),该机制可暂时富集单泛素化的PCNA。
Nat Commun. 2025 Jul 30;16(1):6991. doi: 10.1038/s41467-025-61768-0.
2
USP39: a key regulator in malignant tumor progression.USP39:恶性肿瘤进展中的关键调节因子。
Front Oncol. 2025 Jul 2;15:1556011. doi: 10.3389/fonc.2025.1556011. eCollection 2025.
3
AKT and DUBs: a bidirectional relationship.AKT与去泛素化酶:一种双向关系。

本文引用的文献

1
Molecular basis for ubiquitin/Fubi cross-reactivity in USP16 and USP36.USP16 和 USP36 中泛素/Fubi 交叉反应的分子基础。
Nat Chem Biol. 2023 Nov;19(11):1394-1405. doi: 10.1038/s41589-023-01388-1. Epub 2023 Jul 13.
2
UniProt: the Universal Protein Knowledgebase in 2023.UniProt:2023 年的通用蛋白质知识库。
Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531. doi: 10.1093/nar/gkac1052.
3
Cryo-EM reveals a mechanism of USP1 inhibition through a cryptic binding site.冷冻电镜揭示了通过一个隐蔽结合位点抑制USP1的机制。
Cell Mol Biol Lett. 2025 Jul 7;30(1):77. doi: 10.1186/s11658-025-00753-3.
4
The deubiquitinase USP7 stabilizes HER2 expression and promotes breast cancer progression.去泛素化酶USP7可稳定HER2表达并促进乳腺癌进展。
Neoplasia. 2025 Aug;66:101192. doi: 10.1016/j.neo.2025.101192. Epub 2025 Jun 4.
5
USP39 promote post-translational modifiers to stimulate the progress of cancer.USP39促进翻译后修饰以刺激癌症进展。
Discov Oncol. 2025 May 13;16(1):749. doi: 10.1007/s12672-025-02573-5.
6
Exploring the cancerous nexus: the pivotal and diverse roles of USP39 in cancer development.探索癌性关联:USP39在癌症发展中的关键和多样作用。
Discov Oncol. 2025 May 10;16(1):715. doi: 10.1007/s12672-025-02480-9.
7
The role of ubiquitination and deubiquitination in the pathogenesis of non-alcoholic fatty liver disease.泛素化与去泛素化在非酒精性脂肪性肝病发病机制中的作用
Front Immunol. 2025 Apr 11;16:1535362. doi: 10.3389/fimmu.2025.1535362. eCollection 2025.
8
Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects.用于癌症治疗的泛素特异性蛋白酶抑制剂:最新进展与未来展望
Biomolecules. 2025 Feb 7;15(2):240. doi: 10.3390/biom15020240.
9
Activation and Reactivity of the Deubiquitinylase OTU Cezanne-2 from MD Simulations and QM/MM Calculations.基于分子动力学模拟和量子力学/分子力学计算研究去泛素化酶OTU Cezanne-2的激活与反应活性
J Chem Inf Model. 2025 Jan 27;65(2):921-936. doi: 10.1021/acs.jcim.4c01964. Epub 2025 Jan 9.
10
Targeting the ubiquitin-proteasome system: a novel therapeutic strategy for neuroblastoma.靶向泛素-蛋白酶体系统:一种治疗神经母细胞瘤的新策略。
Front Oncol. 2024 Sep 26;14:1443256. doi: 10.3389/fonc.2024.1443256. eCollection 2024.
Sci Adv. 2022 Sep 30;8(39):eabq6353. doi: 10.1126/sciadv.abq6353. Epub 2022 Sep 28.
4
Mitoxantrone stacking does not define the active or inactive state of USP15 catalytic domain.米托蒽醌叠加并不定义 USP15 催化结构域的活性或非活性状态。
J Struct Biol. 2022 Sep;214(3):107862. doi: 10.1016/j.jsb.2022.107862. Epub 2022 May 20.
5
Structural Insights into the Catalytic Mechanism and Ubiquitin Recognition of USP34.USP34 的催化机制和泛素识别的结构见解。
J Mol Biol. 2022 Jul 15;434(13):167634. doi: 10.1016/j.jmb.2022.167634. Epub 2022 May 16.
6
Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches.USP30 抑制增强 Parkin 介导的线粒体自噬的研究:工具和方法。
Biochem J. 2021 Dec 10;478(23):4099-4118. doi: 10.1042/BCJ20210508.
7
Insert L1 is a central hub for allosteric regulation of USP1 activity.插入 L1 是 USP1 活性变构调节的中央枢纽。
EMBO Rep. 2021 Apr 7;22(4):e51749. doi: 10.15252/embr.202051749. Epub 2021 Feb 23.
8
The Clustal Omega Multiple Alignment Package.Clustal Omega多序列比对软件包。
Methods Mol Biol. 2021;2231:3-16. doi: 10.1007/978-1-0716-1036-7_1.
9
UCSF ChimeraX: Structure visualization for researchers, educators, and developers.UCSF ChimeraX:面向研究人员、教育工作者和开发者的结构可视化工具。
Protein Sci. 2021 Jan;30(1):70-82. doi: 10.1002/pro.3943. Epub 2020 Oct 22.
10
Families and clans of cysteine peptidases.半胱氨酸肽酶的家族与宗族。
Perspect Drug Discov Des. 1996;6(1):1-11. doi: 10.1007/BF02174042.